These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17240111)

  • 1. Cryptococcal meningitis in a patient treated with infliximab.
    Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab.
    Wingfield T; Jani M; Krutikov M; Mayer J; Uriel A; Marks J; Ustianowski AP
    Rheumatology (Oxford); 2011 Sep; 50(9):1725-7. PubMed ID: 21700684
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Asano Y; Kano Y; Shiohara T
    Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel.
    Shrestha RK; Stoller JK; Honari G; Procop GW; Gordon SM
    Respir Care; 2004 Jun; 49(6):606-8. PubMed ID: 15165294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR; Gilliland WR; Miller RS; Decker CF
    Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
    Geraghty EM; Ristow B; Gordon SM; Aronowitz P
    Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
    MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG; Colmenero JD; Irigoyen MV
    J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.
    Richette P; Dieudé P; Damiano J; Lioté F; Orcel P; Bardin T
    J Rheumatol; 2004 Oct; 31(10):2079-81. PubMed ID: 15468380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
    Neven N; Vis M; Voskuyl AE; Wolbink GJ; Nurmohamed MT; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2005 Apr; 64(4):645-6. PubMed ID: 15769924
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.
    Scollard DM; Joyce MP; Gillis TP
    Clin Infect Dis; 2006 Jul; 43(2):e19-22. PubMed ID: 16779736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab.
    Esser AC; Abril A; Fayne S; Doyle JA
    J Am Acad Dermatol; 2004 May; 50(5 Suppl):S75-7. PubMed ID: 15097933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
    Matsumoto T; Tanaka T; Kawase I
    N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Verhoeven AC; Boers M
    Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
    Imagama T; Taguchi T
    Nihon Rinsho; 2013 Jul; 71(7):1209-13. PubMed ID: 23961668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
    Taniguchi H; Izumi S
    Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.